24 results
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
products, hire and retain skilled staff and key personnel, rely on third-party providers, protect its intellectual property and face litigation risk
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
results from pre-clinical and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
28 Jul 23
Interim condensed consolidated financial statements of
8:31am
and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely on third-party providers
6-K
EX-99.2
5kftqq2anji05stfym
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.2
vx3c9b l74st514
15 Aug 22
Interim Condensed Consolidated Statements of Financial Position
8:00am
20-F
EX-1.3
243h ui347
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.12
waks8i
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.16
dt56u3gpz2
22 Jun 22
Annual report (foreign)
5:04pm
20-F
gztc80m3xf6 r2yuy
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-15.1
044 kvgtshl2p095iia
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.8
6674u9 x28xo7hai
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-11.1
b0c g674sq3gxyb
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.1
0i9xsmx
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.3
v633bcq7
22 Jun 22
Current report (foreign)
8:00am
40-F
EX-99.1
geb d93kax2daf
28 May 21
Annual report (Canada)
12:12pm
40-F
EX-99.3
horom0i04k
28 May 21
Annual report (Canada)
12:12pm
6-K
EX-99.2
wcmm rdzg8zq6iu3oe
30 Dec 20
Current report (foreign)
9:10pm
6-K
EX-99.7
oe3gwk4ow q7bt6
5 Aug 20
Condensed Consolidated Interim Statements of Financial Position
12:29pm